Patient vulnerability in stereotactic arrhythmia radioablation (STAR): a preliminary ethical appraisal from the STOPSTORM.eu consortium
Publication date
2024-10
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by
Abstract
This preliminary ethical appraisal from the STOPSTORM.eu consortium is meant to raise critical points that clinicians administering stereotactic arrhythmia radioablation should consider to meet the highest standards in medical ethics and thus promote quality of life of patients recruited for radiotherapy treatments at a stage in which they experience a significant degree of vulnerability.
Keywords
Bioethics, Cardiovascular disease, Ethics in research, Stereotactic Body Radiotherapy, Ventricular tachycardia, Radiology Nuclear Medicine and imaging, Oncology
Citation
Botrugno, C, Crico, C, Iori, M, Blanck, O, Blamek, S, Postema, P G, Quesada, A, Pruvot, E, Verhoeff, J J C & De Panfilis, L 2024, 'Patient vulnerability in stereotactic arrhythmia radioablation (STAR) : a preliminary ethical appraisal from the STOPSTORM.eu consortium', Strahlentherapie und Onkologie, vol. 200, no. 10, pp. 903-907. https://doi.org/10.1007/s00066-024-02230-w